ARCHIVE

• GVP to Be Stipulated in Amended PAL Ordinances
  June 30, 2003

• REGULATORY NEWS IN BRIEF
  June 30, 2003

• WORLD NEWS IN BRIEF
  June 30, 2003

• NEW PRODUCTS
  June 30, 2003

• BUSINESS NEWS IN BRIEF
  June 30, 2003

• FPMAJ Committee Proposes Revisions to NHI Pricing Rules
  June 30, 2003

• Business Challenges Discussed: UBS Conference
  June 30, 2003

• Meet the Leaders (21)
  June 30, 2003

• New Drug Information Supply System to Be Strengthened
  June 23, 2003

• 8 Ingredients Including New Kits Added to NHI List
  June 23, 2003

• Aiming to Reduce Costs by \10 Billion: Mr Kobori of Mitsubishi Pharma
  June 23, 2003

• Teijin Pharma to Be Firmly Set Up: Mr Ohyagi
  June 23, 2003

• Current NHI Pricing Rule's Perfection Level Is High: Mr Yashiro
  June 23, 2003

• Meiji, Solvay File for Social Anxiety as New Indication for SSRI Fluvoxamine
  June 23, 2003

• BULLETIN
  June 23, 2003

• Kuraya Sanseido to Cut Costs Without Undermining Marketing Ability
  June 23, 2003

• WORLD NEWS IN BRIEF
  June 23, 2003

• BUSINESS NEWS IN BRIEF
  June 23, 2003

• Press Seminar
  June 23, 2003

• WEBSITE NEWS
  June 23, 2003

ページ

• « 先頭
• ‹ Prev
• …
• 590
• 591
• 592
• 593
• 594
• 595
• 596
• 597
• 598
• …
• Next ›
• 最終 »